Financial Incentives for Smoking Treatment II

Not Applicable

• Conditions: Smoking Cessation; Tobacco Use Cessation

• Registration Number: NCT03979885
• Lead Sponsor: University of California, Los Angeles

Brief Summary

Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-06-04
• Study First Submitted QC: 2019-06-06
• Study First Posted: 2019-06-07
• Study Start: 2020-01-06
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-01
• Last Update Posted: 2024-05-02
• Primary Completion: 2024-12-31
• Study Completion: 2025-06-30

Recruitment & Eligibility

• Status: ENROLLING_BY_INVITATION
• Sex: All
• Target Recruitment: 1058

Inclusion Criteria

1. age ≥ 18 years
2. smoked tobacco during the prior 30 days,
3. have an active U.S. phone number and address,
4. can provide consent in English or Spanish and
5. are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit

Exclusion Criteria

1. use only smokeless tobacco,
2. are pregnant or breastfeeding,
3. are discharged to an institution (e.g., nursing home, long-term care facility),
4. are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Smoking abstinence assessed by self-report and biochemically verified by salivary cotinine	6 months	Assessed by self-report questionnaire, and biochemically verified by salivary cotinine

Secondary Outcome Measures

Name	Time	Method
Quality of life as measured by PROMIS-29 Profile v2.0	12 months	Assessed by phone interviews.
Short term return on investment of using financial incentives to promote smoking cessation (Cost analysis)	12 months	Cost analysis involving hospital utilization data, electronic health records and patient-reported healthcare utilization
Use of evidence based treatment (e.g. counseling and smoking cessation medications) assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report	2 months	Assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report
Long term return on investment of using financial incentives to promote smoking cessation (Cost analysis)	3 years	Cost analysis involving hospital utilization data, electronic health records and patient-reported healthcare utilization

Trial Locations

Locations (2)

David Geffen School of Medicine; 🇺🇸 Los Angeles, California, United States

NYU Langone Health; 🇺🇸 New York, New York, United States